Skip to main content
Play
Back to Top

On our Integrated Human Practice page, you will find a comprehensive account of iGEM Team BUCT-China 2024's journey in advancing MicroDetect. This includes detailed interactions with individuals from diverse backgrounds and levels, insights from the practical process, and the team's considerations of the values of various stakeholders, as well as feedback-based adjustments made at different stages of MicroDetect's technological experimentation.

BUCT-China 2024's primary focus is on addressing the critical question: how can we achieve accurate, rapid, efficient, simple, convenient, and affordable diagnosis of complex diseases that currently lack reliable methods for timely diagnosis? Through extensive brainstorming sessions with the entire Human Practices team, we identified a series of stakeholders relevant to this issue. Throughout this year's journey of exploration, we actively engaged all stakeholders, encouraging their participation and fostering close connections with MicroDetect.Together, we explored the potential and importance of MicroDetect, its feasibility, and gained a deep understanding of their values, needs, unique perspectives on the problem, and the potential impact of MicroDetect on their respective domains.

Inspired by iGEM TU Eindhoven 2022, we first applied the Mendelow Matrix to assess each stakeholder's priority and relevance on the axes of influence and interest. This helped us clearly understand their level of involvement, motivations, contributions, the broader groups they represent, and their interrelationships. Next, we adopted the stakeholder categorization method used by iGEM TU Eindhoven 2023, classifying them into six sectors based on their professional backgrounds: SCIENCE/academic research, HEALTH/medical care, EDUCATION/teachers and students, BUSINESS & INDUSTRY, PUBLIC & COMMUNITY/ safety and sustainability, and REGULATION/ethics and law.Together, we explored how to translate their value needs into the project and collected valuable input based on their expertise. This enabled us tobuild a value flow for the project model and adjust our strategies in a timely manner.

Undeniably, a feedback mechanism is crucial for the growth and success of any startup project. If we do not understand how people perceive the operations or products involved in MicroDetect, it will be challenging to develop in ways that are meaningful to our audience.[1]


“Providing true value to all stakeholders is key.” —— Sid Mohasseb

Icon 1 Description

SCIENCE/academic research

HEALTH/medical care

Icon 2 Description
Icon 3 Description

EDUCATION/teachers and students

BUSINESS & INDUSTRY

Icon 4 Description
Icon 5 Description

PUBLIC & COMMUNITY/safety and sustainability

REGULATION/ethics and law

Icon 6 Description

The timeline below showcases all the significant events in BUCT-China 2024's journey to complete MicroDetect, fully reflecting our diverse and rich interactions with various stakeholders. We have inherited and further enhanced the narrative model of "WHW" from BUCT-China 2023. On the left side of the timeline, we focus more on "Hearing From The World," exploring the two main questions: "WHY we decided to start this year’s journey" and "How did we achieve our goals." On the right side of the timeline, we lean towards "Giving To The World," highlighting "WHAT we can contribute to society and the world." We know that competitiveness in the new world of constant flux is only achieved by redefining our approach and shifting our focus from outcomes to evolving reasons, motivations and causes for decisions and actions. We must restore our perspective on delivering true value to all stakeholders and approach tomorrow with an open canvas for change.[2]

BUCT-China 2024 strives to listen to the world, amplifying the voices of the people and engaging with the real environmental situation. At the same time, we have received positive feedback, which has motivated us to continue our work in this field and highlighted areas where MicroDetect can be improved and enhanced. Throughout this year, we have taken to various stages, conducting activities targeted at different audiences with diverse themes. We have made every effort to promote the core concept of "precision medicine" and the emerging molecular diagnostic technologies, leaving a lasting impact on the public and imparting the unique values of science, inclusivity, innovation, and health associated with iGEM and the diagnostic village. Finally, we have reflected on whether our project and research approach are beneficial and responsible to the world, aiming to create a complete feedback loop.


“I just live by the ABCs: Adventurous, Brave, Creative.” —— The Secret Life of Walter Mitty


Hearing from the World
Giving to the World
Mar 17
icon1
icon2
 icon

Brainstorming

BUCT-China 2024

Apr 7
icon1
icon2
 icon

Survey

BUCT-China 2024

Apr 10
icon1
icon2
HEALTH PUBLIC & COMMUNITY icon

Interview

HEALTH PUBLIC & COMMUNITY

Dr. Zhang

Department of Traditional Chinese Medicine, a community hospital in Chaoyang, Beijing

Apr 13
icon1
icon2
SCIENCE icon

Lecture

SCIENCE

Prof. Xiao Yi

Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

Apr 14
icon1
icon2
EDUCATION icon

iGEM Lecture

EDUCATION

BUCT-China 2024

Beijing University of Chemical Technology

Apr 19
icon1
icon2
HEALTH icon

Interview

HEALTH

Dr. Li Xu

China-Japan Friendship Hospital

Apr 20
icon1
icon2
HEALTH icon

Interview

HEALTH

Dr. Yahui Lin

Fuwai Hospital, Chinese Academy of Medical Science

Apr 21
icon1
icon2
BUSINESS & INDUSTRY REGULATION icon

Interview

BUSINESS & INDUSTRY REGULATION

Mr. Zhimin Yan

Head and supervisor of the R&D department of a biopharmaceutical foreign company in Beijing.

Critical Juncture
icon1
icon2

Critical Juncture

Apr 27
icon1
icon2
BUSINESS & INDUSTRY icon

Visit

BUSINESS & INDUSTRY

Beijing Fulongkangtai Biotechnology Co., Ltd.

Apr 27
icon1
icon2
BUSINESS & INDUSTRY icon

Interview

BUSINESS & INDUSTRY

Dr. Zhenjian Du

Beijing Fulongkangtai Biotechnology Co., Ltd.

Reflection
icon1
icon2

Reflection

May 5
icon1
icon2
BUSINESS & INDUSTRY icon

Visit

BUSINESS & INDUSTRY

Zhongke Inno (Beijing) International Medical Research Institute

May 11
icon1
icon2
BUSINESS & INDUSTRY icon

Visit

BUSINESS & INDUSTRY

Lunan Pharmaceutical Group

Reflection
icon1
icon2

Reflection

May 24
icon1
icon2
SCIENCE icon

Interview

SCIENCE

Prof. Moshe Szyf

Department of Pharmacology & Therapeutics, McGill University

Mar 24
icon1
icon2
SCIENCE icon

Interview

SCIENCE

Prof. Xiong Ji

School of Life Sciences, Peking University

May 25
icon1
icon2
BUSINESS & INDUSTRY icon

Visit

BUSINESS & INDUSTRY

DP Technology

Critical Juncture
icon1
icon2

Critical Juncture

May 31
icon1
icon2
EDUCATION icon

Popularization

EDUCATION

Asia-Pacific Experimental School of Beijing Normal University

Jun 13
icon1
icon2
EDUCATION icon

Popularization

EDUCATION

King Mongkut's Institute of Technology Ladkrabang

Jun 17
icon1
icon2
EDUCATION icon

Popularization

EDUCATION

Beijing Ritan High School

Jun 29
icon1
icon2
EDUCATION icon

Popularization

EDUCATION

School of International Education, Beijing University of Chemical Technology

Jul 11
icon1
icon2
EDUCATION icon

Popularization

EDUCATION

Impoverished and disaster-stricken areas in Kenya

Jul 22
icon1
icon2
EDUCATION icon

Popularization

EDUCATION

Mrs. Camille Volunteer Teacher

Impoverished and disaster-stricken areas in East Jakarta, Indonesia

Reflection
icon1
icon2

Reflection

Jul 23
icon1
icon2
SCIENCE icon

Interview

SCIENCE

Prof. Jianbin Wang

School of Life Sciences, Tsinghua University

Jul 23
icon1
icon2
SCIENCE icon

Interview

SCIENCE

Prof. Yi Lin

School of Life Sciences, Tsinghua University

Jul 24
icon1
icon2
SCIENCE icon

Interview

SCIENCE

Prof. Carsten Janke

Institut Curie, France

Aug 1
icon1
icon2
EDUCATION icon

Collaboration

EDUCATION

Yiye-China

Aug 5
icon1
icon2
SCIENCE icon

Visit

SCIENCE

Shenzhen Bay Laboratory

Critical Juncture
icon1
icon2

Critical Juncture

Aug 5
icon1
icon2
SCIENCE icon

Interview

SCIENCE

Prof. Yi Yang

Institute of Systems and Physical Biology, Shenzhen Bay Laboratory

Aug 5
icon1
icon2
SCIENCE icon

Interview

SCIENCE

Dr. Qianqian Li

Institute of Systems and Physical Biology, Shenzhen Bay Laboratory

Reflection
icon1
icon2

Reflection

Aug 5
icon1
icon2
SCIENCE icon

Interview

SCIENCE

Prof. Zhuobin Liang

Institute of Molecular Physiology, Shenzhen Bay Laboratory

Aug 5
icon1
icon2
SCIENCE icon

Interview

SCIENCE

Prof. Yu-Hsuan Tsai

Institute of Molecular Physiology, Shenzhen Bay Laboratory

Reflection
icon1
icon2

Reflection

Aug 7
icon1
icon2
BUSINESS & INDUSTRY PUBLIC & COMMUNITY icon

Lecture

BUSINESS & INDUSTRY PUBLIC & COMMUNITY

Ruiyun Ba , Artist of the Central Academy of Fine Arts/Yongde Cai , CEO of Synorg Biotechnology Ltd./Kehan Wang , CFO of Powered Carbon Biotechnology Ltd.

Aug 8
icon1
icon2
PUBLIC & COMMUNITY icon

Popularization

PUBLIC & COMMUNITY

Scene of the third Synbio Challenges

Aug 10
icon1
icon2
BUSINESS & INDUSTRY icon

Interview

BUSINESS & INDUSTRY

Prof. Moshe Szyf

HKG Epitherapeutics Ltd.

Aug 10
icon1
icon2
BUSINESS & INDUSTRY icon

Visit

BUSINESS & INDUSTRY

HKG Epitherapeutics Ltd.

Reflection
icon1
icon2

Reflection

BUCT-China 2024

Aug 13
icon1
icon2
HEALTH icon

Interview

HEALTH

Dr. Ping Li

Sichuan Orthopedic Hospital, Foot and Ankle Surgery

Aug 16
icon1
icon2
HEALTH BUSINESS & INDUSTRY PUBLIC & COMMUNITY icon

Interview

HEALTH BUSINESS & INDUSTRY PUBLIC & COMMUNITY

Mrs. Qiong Deng

Director of Meinian Health Chengdu

Aug 18
icon1
icon2
PUBLIC & COMMUNITY icon

Popularization

PUBLIC & COMMUNITY

All 11 iGEM teams in China

Aug 31
icon1
icon2
PUBLIC & COMMUNITY icon

Popularization

PUBLIC & COMMUNITY

BUCT-China 2024

Beijing University of Chemical Technology

Aug 31
icon1
icon2
HEALTH icon

Interview

HEALTH

Dr. Jianfeng Wang

China-Japan Friendship Hospital

Sep 7
icon1
icon2
HEALTH icon

Interview

HEALTH

Dr. Li Xu

China-Japan Friendship Hospital

Sep 14
icon1
icon2
HEALTH REGULATION icon

Interview

HEALTH REGULATION

Dr. Benqiang Rao

Beijing Shijitan Hospital, Capital Medical University

Sep 21
icon1
icon2
HEALTH icon

Interview

HEALTH

Dr. Yu Zhang

Tianjin Hospital of ITCWM Nankai Hospital

Sep 27
icon1
icon2
REGULATION icon

Biosafety & Bioethics in Synthetic Biology

REGULATION

All 18 iGEM teams in China

(Organized by JLU-NBBMS & XJTLU-SOFTWARE)

Sep 30
icon1
icon2
PUBLIC & COMMUNITY icon

Sustainable Development Goals in Synthetic Biology

PUBLIC & COMMUNITY

All 6 iGEM teams in China

(Organized by BIT-China)

Reflection
icon1
icon2

Reflection

Close the feedback loop
icon1
icon2

Close the feedback loop


References

[1] How To Build A Strong Feedback Loop For Your Tech Startup. Accessed September 16, 2024. https://www.forbes.com/councils/forbestechcouncil/2024/09/16/how-to-build-a-strong-feedback-loop-for-your-tech-startup/

[2] Why Harmonizing Stakeholder Interests Is Key In Business Today. Accessed August 1, 2024. https://www.forbes.com/councils/forbesbusinesscouncil/2024/08/01/why-harmonizing-stakeholder-interests-is-key-in-business-today/

[3] Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 Apr 4. doi: 10.3322/caac.21834.